Evidence map›Paper›PMID 29177100›Full record

ReviewBMJ global health2017

20 years of gender mainstreaming in health: lessons and reflections for the neglected tropical diseases community.

Sally Theobald, Eleanor E MacPherson, Laura Dean, Julie Jacobson, Camilla Ducker, Margaret Gyapong, Kate Hawkins, Thoko Elphick-Pooley, Charles Mackenzie, Louise A Kelly-Hope and 2 more

Abstract readReview
In one paragraph

Review in BMJ global health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Factors Associated with the Acceptability of Mass Drug Administration for Filariasis: A Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sally TheobaldDepartment of International Public Health, COUNTDOWN Consortium and RiNGs Consortium, Liverpool School of Tropical Medicine, Liverpool, UK.
Eleanor E MacPhersonDepartment of International Public Health, COUNTDOWN Consortium, Liverpool School of Tropical Medicine, Liverpool, UK.
Laura DeanDepartment of International Public Health, COUNTDOWN Consortium, Liverpool School of Tropical Medicine, Liverpool, UK.
Julie JacobsonBill and Melinda Gates Foundation, Seattle, Washington, USA.
Camilla DuckerDepartment for International Development, London, UK.
Margaret GyapongCOUNTDOWN Consortium, Institute for Health Research, University of Health and Allied Sciences, Ho, Ghana.
Kate HawkinsRiNGs Consortium and Pamoja Communications, Brighton, UK.
Thoko Elphick-PooleyUniting to Combat NTDs, Brighton, UK.
Charles MackenzieDepartment of Parasitology, Liverpool School of Tropical Medicine, Decatur, Georgia, USA.
Louise A Kelly-HopeCentre for Neglected Tropical Diseases, Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, UK.
Fiona M FlemingSchistosomiasis Control Initiative, Imperial College London, London, UK.
Pamela S MbabaziDepartment of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Neglected tropical diseases (NTDs) affect the poorest of the poor. NTD programmes can and should rise to the challenge of playing a part in promoting more gender equitable societies. Gender equity shapes poverty and the experience of disease in multiple ways; yet to date, there has been little attention paid to gender equity in NTD control efforts. Drawing on a synthesis of relevant literature, the tacit knowledge and experience of the authors, and discussions at a meeting on women, girls and NTDs, this analysis paper distills five key lessons from over 20 years of gender mainstreaming in health. The paper links this learning to NTDs and Mass Drug Administration (MDA). Our first lesson is that tailored gender frameworks support gender analysis within research and programming. We present a gender review framework focusing on different MDA strategies. Second, gender interplays with other axes of inequality, such as disability and geographical location; hence, intersectionality is important for inclusive and responsive NTD programmes. Third, gender, power and positionality shape who is chosen as community drug distributors (CDDs). How CDDs interact with communities and how this interface role is valued and practised needs to be better understood. Fourth, we need to unpack the gender and power dynamics at household level to assess how this impacts MDA coverage and interactions with CDDs. Finally, we need to collect and use sex disaggregated data to support the development of more equitable and sustainable NTD programmes.

Indexed as

health systems

Identifiers

PMID29177100
PMCPMC5687534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.